Anifrolumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Anifrolumab Usage And Synthesis

Uses

Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research[1][2].

References

[1] Furie R, et al. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386. DOI:10.1002/art.39962
[2] Riggs JM, et al. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. Lupus Sci Med. 2018 Apr 5;5(1):e000261. DOI:10.1136/lupus-2018-000261

Anifrolumab(1326232-46-5)Related Product Information

• Atibuclimab
• Teprotumumab
• Marstacimab
• Abrilumab
• Pacmilimab
• Olaratumab
• Codrituzumab
• abciximab
• Enokizumab
• Cinpanemab